1-2 of 2
Vladimir Lebedev
Close
Sort by
Journal Articles

A Phase 2, International, Multicenter, Prospective Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients with Solid Tumors Undergoing Chemotherapy

Noah Federman, Monica Desiree Dragomir, Zoryana Kizyma, Vladimir Lebedev, Jelena Roganovic, Peter Bias, Andreas Lammerich, Zipi Roth-Ben Arie, Linglong Zou, Anton Buchner
Journal: Blood
Blood (2017) 130 (Supplement 1): 2271.
https://doi.org/10.1182/blood.V130.Suppl_1.2271.2271
Published: 2017
Journal Articles

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, John D. Grainger, MD BMBch, MRCP, FRCPATH, Purificacion Garcia de Miguel, Jenny M. Despotovic, DO, MS, Franco Locatelli, Thirachit Chotsampancharoen, MD, Elena K. Donyush, Julian Sevilla Navarro, MD, Bunchoo Pongtanakul, MD, Patcharee Komvilaisak, MD, Darintr Sosothikul, MD, Victor S. Blanchette, MD FRCPC, Guillermo I. Drelichman, MD, Lakshmanan Krishnamurti, MD, Nongnuch Sirachainan, MD, Philip Connor, MD, Michele David, MD FRCPC, Susanne Holzhauer, MD MSc, Vladimir Lebedev, Richard S. Lemons, MD PhD, Dagmar Pospisilova, MD PhD, Ugo Ramenghi, MD, Koh B. Boayue, MD, Dana C. Matthews, MD, Lisa M. Marcello, BA, MS, Malini Iyengar, PhD, Geoffrey W. Chan, MD, Karen D. Chagin, MD, Dickens Theodore, MD MPH, Kalpana K. Bakshi, BS, MS, Christine K. Bailey, PhD
Journal: Blood
Blood (2014) 124 (21): 1450.
https://doi.org/10.1182/blood.V124.21.1450.1450
Published: 2014